NovelStem International specializes in diagnostic technology, offering services in developmental biology, reproductive medicine, cancer research, regenerative medicine, and genetic disease modeling. The company's core focus is developing and commercializing diagnostic tools that predict patients' resistance to anti-cancer drugs, enabling targeted treatments and potentially reducing chemotherapy resistance.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.